The Prevalence of Scabies and Impetigo in the Solomon Islands: A Population-Based Survey

PLoS Neglected Tropical Diseases

Volumn 10, Issue 6, 2016, Pages

  Mason, Daniel S ^a   Marks, Michael ^b,c   Sokana, Oliver ^d   Solomon, Anthony W ^b,c,e   Mabey, David C ^b,c   Romani, Lucia ^f   Kaldor, John ^f   Steer, Andrew C ^a,g   Engelman, Daniel ^a,g  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^d Ministry of Health   (Solomon Islands)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY REGIONS; CHILD; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ERYTHEMA; FEMALE; HEALTH SURVEY; HOUSEHOLD; HUMAN; IMPETIGO; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; POPULATION MODEL; PRESCHOOL CHILD; PREVALENCE; PUS; RURAL POPULATION; SCABIES; SOLOMON ISLANDS; MELANESIA; ODDS RATIO; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMPETIGO; INFANT; MALE; MELANESIA; ODDS RATIO; POPULATION SURVEILLANCE; PREVALENCE; SCABIES; YOUNG ADULT;

EID: 84978998141     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004803     Document Type: Article

References (27)

1. Hay RJ, Steer AC, Engelman D, Walton S, Scabies in the developing world—its prevalence, complications, and management. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012;18(4):313–23. Epub 2012/03/21. doi: 10.1111/j.1469-0691.2012.03798.x22429456;
2. Walton SF, Currie BJ, Problems in diagnosing scabies, a global disease in human and animal populations. Clinical microbiology reviews. 2007;20(2):268–79. Epub 2007/04/13. doi: 10.1128/cmr.00042-0617428886;
3. Steer AC, Jenney AW, Kado J, Batzloff MR, La Vincente S, Waqatakirewa L, et al. High burden of impetigo and scabies in a tropical country. PLoS neglected tropical diseases. 2009;3(6):e467. Epub 2009/06/24. doi: 10.1371/journal.pntd.000046719547749;
4. Bowen AC, Mahe A, Hay RJ, A R.M., Steer AC, Tong SYC, et al. The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma. PLoS ONE. 2015;10(8). Epub 28/08/15.
5. Mahe A, Hay R, Epidemiology and Management of Common Skin Diseases in Children in Developing Countries. Switzerland: World Health Organisation, Department of Child and Adolescent Health and Development; 2005 Contract No.: WHO/FCH/CAH/05.12.
6. Hoy WE, White AV, Dowling A, Sharma SK, Bloomfield H, Tipiloura BT, et al. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney international. 2012;81(10):1026–32. Epub 2012/02/03. doi: 10.1038/ki.2011.47822297679;
7. Parks T, Smeesters PR, Steer AC, Streptococcal skin infection and rheumatic heart disease. Current opinion in infectious diseases. 2012;25(2):145–53. Epub 2012/02/14.
8. Romani L, Steer AC, Whitfeld MJ, Kaldor JM, Prevalence of scabies and impetigo worldwide: a systematic review. The Lancet Infectious diseases. 2015. Epub 2015/06/20. doi: 10.1016/s1473-3099(15)00132-226088526;
9. Currie BJ, Connors CM, Krause VL, Scabies programs in aboriginal communities. The Medical journal of Australia. 1994;161(10):636–7. Epub 1994/11/21. 7968739;
10. Gulati PV, Singh KP, Braganza C, Role of sociocultural and environmental factors in the cause of scabies. International journal of dermatology. 1977;16(4):281–3. Epub 1977/05/01. 863573;
11. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions. Journal of Investigative Dermatology. 2014;(134):1527–34. Epub 21/11/2013. doi: 10.1038/jid.2013.44624166134
12. United Nations. United Nations Development Programme Human Development Reports; Solomon Islands [cited 2015 23/08/2015]. Available from: http://hdr.undp.org/en/countries/profiles/SLB.
13. World Health Organisation. Solomon Islands: WHO statistical profile Switzerland2015 [updated January 2015]. Available from: http://www.who.int/gho/countries/slb.pdf?ua=1.
14. Solomon Islands National Statistical Office, Ministry of Finance and Treasury. Solomon Islands Government; 2009 Population & Housing Census National Report Volume 2. Honiara, Solomon Islands: Solomon Islands Government Ministry of Finance and Treasury; 2009 2011. Report No.
15. Marks M, Vahi V, Sokana O, Chi K-H, Puiahi E, Kilau G, Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws. PLoS neglected tropical diseases. 2015;9(8).
16. Auto J, Ogaoga D, Nasi T, Tovosia S, Bae'rodo D, Martin T, et al. Solomon Islands standard treatment manual for children. 3rd ed. Solomon Islands2009.
17. Northridge M, Public health methods—attributable risk as a link between causality and public health action. American Journal of Public Health. 1995;(85):1202–4. 7661224
18. Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, Wate C, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bulletin of the World Health Organization. 2005;83(1):34–42. Epub 2005/02/01. /S0042-96862005000100012. 15682247;
19. Haar K, Romani L, Filimone R, Kishore K, Tuicakau M, Koroivueta J, et al. Scabies community prevalence and mass drug administration in two Fijian villages. International journal of dermatology. 2014;53(6):739–45. Epub 2013/10/31. doi: 10.1111/ijd.1235324168177;
20. Romani L, Koroivueta J, Steer AC, Kama M, Kaldor JM, Wand H, et al. Scabies and impetigo prevalence and risk factors in Fiji: a national survey. PLoS neglected tropical diseases. 2015;9(3):e0003452. Epub 2015/03/05. doi: 10.1371/journal.pntd.000345225738499;
21. Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. Mass Drug Administration for Scabies Control in a Population with Endemic Disease. The New England Journal of Medicine. 2015;373(24):2305–13. doi: 10.1056/NEJMoa150098726650152
22. Harris M, Nako D, Hopkins T, Powell D, Kenny C, Carroll C, et al. Skin Infections in Tanna, Vanuatu in 1989. Papua New Guinea Medical Journal. 1992;35(2):137–43. 1509813
23. Dos Santos MM, Amaral S, Harmen SP, Joseph HM, Fernandes JL, Counahan ML, The prevalence of common skin infections in four districts in Timor-Leste: a cross sectional survey. BMC infectious diseases. 2010;10:61. Epub 2010/03/12. doi: 10.1186/1471-2334-10-6120219136;
24. Carapetis JR, Connors C, Yarmirr D, Krause V, Currie BJ, Success of a scabies control program in an Australian aboriginal community. The Pediatric infectious disease journal. 1997;16(5):494–9. Epub 1997/05/01. 9154544;
25. Chosidow O, Scabies. New England Journal of Medicine. 2006;354:1718–27. 16625010
26. Steer AC, Tikoduadua LV, Manalac EM, Colquhoun S, Carapetis JR, Maclennan C, Validation of an Integrated Management of Childhood Illness algorithm for managing common skin conditions in Fiji. Bulletin of the World Health Organization. 2009;87(3):173–9. Epub 2009/04/21. 19377712;
27. Fry AM, Jha HC, Lietman TM, Chaudhary JSP, Bhatta RC, Elliott J, et al. Adverse and Beneficial Secondary Effects of Mass Treatment with Azithromycin to Eliminate Blindness Due to Trachoma in Nepal. Clinical Infectious Diseases. 2002;35(4):394–402.